tradmap

COHR Coherent

$201.50 -5.09%

Data as of close

S&P 500 CompaniesAI Networking & Optics Stocks

Held by SPYVOOIVV

Healthcare · Optical Instruments & Lenses

Coherent (COHR) is a healthcare company in the Optical Instruments & Lenses industry, with a market capitalization of $39.5 billion. Shares last traded at $201.50, 54.2% below their 52-week high. Over the past year the stock is up 51.8%. COHR trades at a price-to-earnings ratio of 49.02, above the Optical Instruments & Lenses median of 37.67. Net profit margin is 11.3%, above the peer median of 10.8%. Revenue grew 22.5% year over year.

Market Cap
$39.5B
Shares Out
195.8M
EPS (TTM)
$4.12
P/E (TTM)*
49.02
P/S Ratio
5.54
P/B Ratio
3.62
Dividend / Share
—
Dividend Yield
—
52-Week High
$440.00
52-Week Low
$123.94
Volume (venue)
538,468
Avg Vol (3m, venue)
306,773.095

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-10.69%
1M
-40.16%
3M
-37.42%
6M
-38.18%
YTD
+9.18%
1Y
+51.81%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
34.56
SMA (50)
$278.11
SMA (200)
$296.64
Price vs SMA50
-27.55%
Price vs SMA200
-32.07%
ATR (14)
$21.36

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$7.1B
Net Income
$805M
Gross Margin
37.5%
Operating Margin
1.4%
Net Margin
11.3%
Return on Equity
7.4%
Return on Assets
4.4%
Current Ratio
2.43
Debt / Equity
0.30
Revenue Growth (YoY)
+22.5%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q4 2026 (derived) $1.20 2026-08-14
FY 2026 $4.12 2026-08-14
Q3 2026 $0.97 2026-05-06
Q2 2026 $0.76 2026-02-04
Q1 2026 $1.19 2025-11-05
Q4 2025 (derived) -$0.81 2025-08-15

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Optical Instruments & Lenses peers

COHR vs 8 industry peers (Optical Instruments & Lenses), by market cap. Data as of close

P/E vs peers
49.02 / 37.67 med
+30% premium
P/S vs peers
5.54 / 8.63 med
-36% discount
Net margin vs peers
11.3% / 10.8% med
above median
1–8 of 8
KLACKLA Corporation$198.1B37.6713.6536.2%-3.68%
COHRCoherent$39.5B49.025.5411.3%-5.09%
NVMINova$9.7B37.2710.9729.4%-2.78%
CAMTCamtek$5.0B97.729.9910.2%-7.37%
OPTXSyntec Optics Holdings, Inc.$212M—7.26-8.3%-16.35%
OPXSOptex Systems Holdings Inc$64M16.541.629.8%+0.71%
MSAIMultiSensor AI Holdings, Inc.$7M———-2.12%
OPTXWSYNTEC OPTICS HOLDINGS, INC.————-21.68%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.